Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GeneDx Holdings Corp.CL A(WGS) | 3,507,164 | 3,507,164 | 0 | $148.84M | $269.56M | 18.03% | +$120.72M |
| Biolife Solutions Inc | 8,707,165 | 8,707,165 | 0 | $218.03M | $226.04M | 15.11% | +$8.01M |
| Revolution Medicines, Inc.(RVMD) | 4,114,283 | 3,699,283 | -415,000 | $186.58M | $161.81M | 10.82% | -$24.78M |
| Sarepta Therapeutics, Inc.(SRPT) | 1,073,500 | 1,073,500 | 0 | $134.07M | $130.53M | 8.73% | -$3.54M |
| Standard BioTools Inc.(LAB) | 71,254,677 | 71,254,677 | 0 | $137.52M | $124.70M | 8.34% | -$12.83M |
| Illumina, Inc.(ILMN) | 750,000 | 750,000 | 0 | $97.81M | $100.22M | 6.70% | +$2.42M |
| Avidity Biosciences Inc | 2,084,841 | 2,045,000 | -39,841 | $95.76M | $59.47M | 3.98% | -$36.29M |
| Codexis, Inc.(CDXS) | 8,100,000 | 8,100,000 | 0 | $24.95M | $38.64M | 2.58% | +$13.69M |
| Relay Therapeutics, Inc.(RLAY) | 9,251,108 | 8,948,574 | -302,534 | $65.50M | $36.87M | 2.47% | -$28.63M |
| Endeavour Silver Corp.(EXK) | 650,000 | 650,000 | 0 | $44.28M | $36.52M | 2.44% | -$7.75M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 170,000 | 140,000 | -30,000 | $46.76M | $32.94M | 2.20% | -$13.81M |
| Beam Therapeutics Inc.(BEAM) | 775,000 | 1,250,000 | +475,000 | $18.99M | $31.00M | 2.07% | +$12.01M |
| Neurogene Inc.(NGNE) | 524,616 | 1,295,361 | +770,745 | $22.01M | $29.61M | 1.98% | +$7.60M |
| Blueprint Medicines Corp | 326,378 | 326,378 | 0 | $30.19M | $28.47M | 1.90% | -$1.72M |
| Intellia Therapeutics, Inc.(NTLA) | 2,000,000 | 2,000,000 | 0 | $41.10M | $23.32M | 1.56% | -$17.78M |
| Verve Therapeutics Inc | 3,995,571 | 3,995,571 | 0 | $19.34M | $22.54M | 1.51% | +$3.20M |
| Denali Therapeutics Inc.(DNLI) | 990,000 | 990,000 | 0 | $28.84M | $20.18M | 1.35% | -$8.66M |
| Structure Therapeutics IncADS | 700,000 | 700,000 | 0 | $30.72M | $18.98M | 1.27% | -$11.74M |
| Septerna, Inc.(SEPN) | 0 | 553,268 | +553,268 | $0 | $12.67M | 0.85% | +$12.67M |
| Veracyte, Inc.(VCYT) | 666,308 | 276,308 | -390,000 | $22.68M | $10.94M | 0.73% | -$11.74M |
| Guardant Health, Inc.(GH) | 350,000 | 350,000 | 0 | $8.03M | $10.69M | 0.71% | +$2.66M |
| Tenaya Therapeutics, Inc.(TNYA) | 6,732,971 | 6,732,971 | 0 | $12.99M | $9.63M | 0.64% | -$3.37M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 250,000 | +250,000 | $0 | $8.21M | 0.55% | +$8.21M |
| Moderna, Inc.(MRNA) | 0 | 175,000 | +175,000 | $0 | $7.28M | 0.49% | +$7.28M |
| 4d Molecular Therapeutics In | 1,150,000 | 1,150,000 | 0 | $12.43M | $6.41M | 0.43% | -$6.03M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 475,000 | 475,000 | 0 | $9.14M | $6.28M | 0.42% | -$2.86M |
| 2seventy Bio Inc | 2,000,000 | 2,000,000 | 0 | $9.44M | $5.88M | 0.39% | -$3.56M |
| Century Therapeutics, Inc.(IPSC) | 3,212,316 | 5,190,506 | +1,978,190 | $5.49M | $5.24M | 0.35% | -$250.6K |
| Fortrea Holdings Inc.(FTRE) | 0 | 275,000 | +275,000 | $0 | $5.13M | 0.34% | +$5.13M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 296,666 | 296,666 | 0 | $5.68M | $4.35M | 0.29% | -$1.33M |
| Tango Therapeutics, Inc.(TNGX) | 1,188,349 | 1,188,349 | 0 | $9.15M | $3.67M | 0.25% | -$5.48M |
| Absci Corporation | 973,260 | 973,260 | 0 | $3.72M | $2.55M | 0.17% | -$1.17M |
| Pacific Biosciences of California, Inc.(PACB) | 1,035,859 | 1,035,859 | 0 | $1.76M | $1.90M | 0.13% | +$134.7K |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 0 | 165,323 | +165,323 | $0 | $1.12M | 0.07% | +$1.12M |
| Prime Medicine, Inc.(PRME) | 367,175 | 367,175 | 0 | $1.42M | $1.07M | 0.07% | -$348.8K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 86,014 | 86,014 | 0 | $455.9K | $596.9K | 0.04% | +$141.1K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 36,493 | 36,493 | 0 | $297.4K | $358.4K | 0.02% | +$60.9K |
| Kronos Bio Inc | 123,839 | 123,839 | 0 | $123.8K | $117.6K | 0.01% | -$6.2K |
| Exscientia PlcADS | 213,900 | 0 | -213,900 | $1.04M | $0 | — | -$1.04M |
| GRAIL, Inc.(GRAL) | 350,000 | 0 | -350,000 | $4.82M | $0 | — | -$4.82M |